In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 3405-77-4, name is 5-Methylisoxazole-3-carboxylic acid, introducing its new discovery. Application In Synthesis of 5-Methylisoxazole-3-carboxylic acid
TRICYCLIC SPIROCYCLE DERIVATIVES AND METHODS OF USE
The present invention relates to novel Tricyclic Spirocycle Derivatives, pharmaceutical compositions comprising the Tricyclic Spirocycle Derivatives and the use of these compounds for treating or preventing allergy, an allergy-induced airway response, congestion, a cardiovascular disease, an inflammatory disease, a gastrointestinal disorder, a neurological disorder, a metabolic disorder, obesity or an obesity-related disorder, diabetes, a diabetic complication, impaired glucose tolerance or aired fasting glucose.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 3405-77-4, and how the biochemistry of the body works.Application In Synthesis of 5-Methylisoxazole-3-carboxylic acid
Reference£º
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem